DSM-5 2013: Diagnostic and statistical manual of mental disorders (DSM-5®). 2013: American Psychiatric Association. Pub.
Thapar A. Cooper M. Eyre o. Langley K Practitioner Review: What have we learnt about the causes of ADHD? Journal of Child Psychology and Psychiatry 54:1 (2013), pp 3–16 https://doi.org/10.1111/j.1469-7610.2012.02611.x
Faraone SV, Larsson H. Genetics of attention deficit hyperactivity disorder. Molecular psychiatry. 2019 Apr;24(4):562.
Archer T, Oscar-Berman M & Blum K. Epigenetics in developmental disorder: ADHD and endophenotypes. Journal of genetic syndrome & gene therapy, 2011, 2(104).
Fayyad J. De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R., Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry, 2007. 190: p. 402-9.
Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM., The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry, 2006. 163(4): p. 716-23.
Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, . . . Lahey BB. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. Journal of Abnormal Psychology, 2012. 121(4), 991-1010. http://dx.doi.org/10.1037/a0027347
Cortese S, Faraone SV, Bernardi S, Wang S, Blanco C. Gender differences in adult attention-deficit/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2016 Apr;77(4):e421-8. doi: 10.4088/JCP.14m09630.
Biederman J, Monuteaux M, Mick E, Spencer T, Wilens T, Silva J, Snyder L, Faraone SV. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006; 36:167–179. http://dx.doi.org/10.1017/S0033291705006410
Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) is associated with early-onset substance use disorders. J Nerv Ment Dis 1997; 185:475–82.
Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. The Journal of clinical psychiatry. 2007;68:4-8.
Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, Biederman J. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry. 2011 Jun; 50(6):543-53.
van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA: Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012; 122: 11–9.
van de Glind G, Konstenius M, Koeter MWJ, et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 2014; 134:158-166. DOI:10.1016/j.drugalcdep.2013.09.026
Charach A, Yeung E, Climans T, Lillie E: Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 2011; 50: 9–21 DOI:10.1016/j.jaac.2010.09.019
Crunelle CL, van den Brinkc W, Moggid F, Konsteniuse M, Francke J, Frances R. Levinf Geurt van de Glindg Zsolt Demetrovicsh Corné Coetzeei Mathias Ludererj Arnt Schellekensk ICASA consensus group Frieda Matthysa. International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. Eur Addict Res 2018;24:43–51 DOI: 10.1159/000487767
Solberg BS, Halmøy A, Engeland A, Igland J, Haavik J, Klungsøyr K.: Gender differences in psychiatric comorbidity: a population‐based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand 2018: 137: 176–186, DOI: 10.1111/acps.12845
Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry, 2014. 171(3): p. 276-93. PMID: 24480998 PMCID: PMC4282137 DOI: 10.1176/appi.ajp.2013.13070966
Connor DF, Steeber J, McBurnett K. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. Journal of Developmental & Behavioral Pediatrics. 2010 Jun 1;31(5):427-40.
Landaas ET, Halmøy A, Oedegaard KJ, Fasmer OB, Haavik J. The impact of cyclothymic temperament in adult ADHD. J Affect Disord. 2012 Dec 15;142(1-3):241-7. Doi: 10.1016/j.jad.2012.04.034.
Barkley RA, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. Journal of the American Academy of Child & Adolescent Psychiatry. 2010 May 1;49(5):503-13.
Faraone SV, Rostain AL, Blader J, Busch B, Childress AC, Connor DF, Newcorn JH. Practitioner Review: Emotional dysregulation in attention‐deficit/hyperactivity disorder–implications for clinical recognition and intervention. Journal of Child Psychology and Psychiatry. 2019 Feb;60(2):133-50..
Aldao A, Gee DG, De Los Reyes A, & Seager I. (2016). Emotion regulation as a transdiagnostic factor in the development of internalizing and externalizing psychopathology: Current and future directions. Development and psychopathology, 28(4pt1), 927-946.
Schreiber LR, Grant JE, & Odlaug BL (2012). Emotion regulation and impulsivity in young adults. Journal of psychiatric research, 46(5), 651-658.
Sobanski E, Banaschewski T, Chen W, Holtmann M, Asherson P, Stringaris A, Buitelaar J, Franke B, Sergeant J, Sonuga-Barke E, Taylor E, Ebstein R, Gill M, Miranda A, Oades R, Roeyers H, Rothenberger A, Steinhausen HC, Mulas F, Anney R, Krumm B, Faraone S. Emotional lability in children and adolescents with Attention Deficit / Hyperactivity Disorder (ADHD): Clinical correlates and familial prevalence. Journal of Child Psychology and Psychiatry, 2010, 51, 915-923 doi.org/10.1111/j.1469-7610.2010.02217.x
Kooij, J. J. S., & Francken, M. H. (2010). Diagnostic interview for ADHD in adults 2.0 (DIVA 2.0). Adult ADHD: Diagnostic assessment and treatment, 33-99.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232–41.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of clinical psychiatry. 1998.
Silverstein MJ, Alperin S. Faraone SV, Kessler RC, and Adler LA: Test–retest reliability of the adult ADHD Self-Report Scale (ASRS) v1.1 Screener in non-ADHD controls from a primary care physician practice. Family Practice, Volume 35, Issue 3, June 2018, p336–341 doi.org/10.1093/fampra/cmx115
Fredriksen M, Dahl AA, Martinsen EW, Klungsøyr O, Haavik J, Peleikis DE. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity. Eur Neuropsychopharmacol. 2014 Dec;24(12):1873-84. doi: 10.1016/j.euroneuro.2014.09.013. Epub 2014 Oct 18.
Barkley R. ADHD in adults: Comorbidity and adaptive impairments. (1997) NIMH Grant number1R01MH054509-01A2.
Barkley RA and Murphy KR: Deficient emotional self-regulation in adults with Attention deficit Hyperactive Disorder (ADHD): The Relative Contribution of Emotional Impulsiveness and ADHD symptoms to Adaptive Impairment in Major Life Activities. J. ADHD Related Disorders (2010) vol 1, 5-28
Surman CB, Biederman J, Spencer T, Miller CA, Petty CR, Faraone SV. Neuropsychological deficits are not predictive of deficient emotional self-regulation in adults with ADHD. Journal of Attention Disorders. 2015 Dec;19(12):1046-53.
Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA psychiatry. 2015 Aug 1;72(8):757-66.
Rehm J, Room R, van den Brink W, & Jacobi F. Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. European Neuropsychopharmacology (2005) 15,4,377-388 doi.org/10.1016/j.euroneuro.2005.04.005
Bratberg GH, Wilsnack SC, Wilsnack R, Haugland SH, Krokstad S, Sund ER and Bjørngaard JH: Gender differences and gender convergence in alcohol use over the past three decades (1984-2008), The HUNT Study, Norway. BMC Public Health. 2016 Aug 5;16:723. doi:10.1186/s12889-016-3384-3.
Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, Zhang H, Smith SM, Pickering RP, Huang B, Hasin DS. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions–III. JAMA psychiatry. 2016 Jan 1;73(1):39-47.
Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. American journal of psychiatry. 2001 Jul 1;158(7):1091-8.
Demontis D, Walters RK, MartinJ, Mattheisen M, Als TD, Agerbo E, ... & Cerrato F. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature genetics, 51(1), 63. doi: https://doi.org/10.1101/145581
Wang K, Gaitsch H, Poon H, Cox NJ, Rzhetsky A. Classification of common human diseases derived from shared genetic and environmental determinants. Nature genetics. 2017 Sep;49(9):1319-1325
Sanchez‐Roige S, Fontanillas P, Elson SL, 23andMe Research Team, Gray JC, de Wit H, Davis LK, MacKillop J, Palmer AA. Genome‐wide association study of alcohol use disorder identification test (AUDIT) scores in 20 328 research participants of European ancestry. Addiction biology. 2019 Jan;24(1):121-31.
Thapar A, Langley K, Asherson P and Gill M. Gene–environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective. The British journal of psychiatry Volume 190, Issue 1January (2007), pp. 1-3.
Wilens TE. Impact of ADHD and its treatment on substance abuse in adults. Journal of Clinical Psychiatry. 2004 Mar 1;65:38-45.
Wilens TE, Adamson J, Sgambati S, Whitely J, Santry A, Monuteaux MC, et al. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict (2007) 16 (Suppl.1):14–21.
Brandt A. Rehm J. & Lev-Ran S. Clinical Correlates of Cannabis Use Among Individuals With Attention Deficit Hyperactivity Disorder. The Journal of nervous and mental disease, (2018). 206(9), 726-732.
Vildalen VU, Brevik EJ, Haavik J, Lundervold AJ. Females with ADHD report more severe symptoms than males on the adult ADHD self-report scale. Journal of attention disorders. 2019 Jul;23(9):959-67.
Robison RJ, Reimherr FW, Marchant BK, Faraone SV, Adler LA, & West SA. Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis. The Journal of clinical psychiatry, (2008). 69(2), 213-221.
Cheetham A, Allen NB. Yücel M, Lubman DI. The role of affective dysregulation in drug addiction. Clinical Psychology Rev. (2010),30,6,621-34